Fiegl, M., Mlineritsch, B., Hubalek, M., Bartsch, R., Pluschnig, U., & Steger, G. G. (2011). Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: Results of an Austrian observational trial. BioMed Central.
Chicago-стиль цитированияFiegl, Michael, Brigitte Mlineritsch, Michael Hubalek, Rupert Bartsch, Ursula Pluschnig, and Günther G. Steger. Single-agent Pegylated Liposomal Doxorubicin (PLD) in the Treatment of Metastatic Breast Cancer: Results of an Austrian Observational Trial. BioMed Central, 2011.
MLA-цитированиеFiegl, Michael, et al. Single-agent Pegylated Liposomal Doxorubicin (PLD) in the Treatment of Metastatic Breast Cancer: Results of an Austrian Observational Trial. BioMed Central, 2011.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.